← Back to patent-cliff list
CAS 114772-38-2
methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate
Codes: TELM-019
Application context (from source-drug indications)
HypertensionTelmisartan/Amlodipine Besylate/HydrochlorothiazideHypertensionRosuvastatin Calcium/TelmisartanHyperlipidaemiaRosuvastatin Calcium/TelmisartanHypertensionAmlodipine Besylate/TelmisartanHypertensionTelmisartanBreast cancerTelmisartanCardiomyopathyTelmisartanAlzheimer's diseaseTelmisartanRisk-reduction measureTelmisartanMyocardial infarctionTelmisartan
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Telmisartan/Amlodipine Besylate/Hydrochlorothiazide | Tier C — Watch / trade | - |
| Rosuvastatin Calcium/Telmisartan | Tier C — Watch / trade | - |
| Amlodipine Besylate/Telmisartan | Tier C — Watch / trade | - |
| Telmisartan | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole→o-cresol→4-hydroxy-3-methylbenzaldehyde→4-hydroxy-3-methyl-5-nitrobenzaldehyde→4-methoxy-3-methyl-5-nitrobenzaldehyde→benzene-1,2-diamine→2-(4-methoxy-3-methyl-5-nitrophenyl)-1-methyl-1H-benzo[d]imidazole→2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)-6-nitroaniline→methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→methyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate
methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→4-bromo-2-methyl-6-nitroaniline→butyraldehyde→6-bromo-4-methyl-2-propyl-1H-benzo[d]imidazole→4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane)→TELM-025→TELM-026→2-bromo-1-methyl-1H-benzo[d]imidazole
1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole→o-cresol→4-hydroxy-3-methylbenzaldehyde→4-hydroxy-3-methyl-5-nitrobenzaldehyde→4-methoxy-3-methyl-5-nitrobenzaldehyde→benzene-1,2-diamine→2-(4-methoxy-3-methyl-5-nitrophenyl)-1-methyl-1H-benzo[d]imidazole→2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)-6-nitroaniline→methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→methyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate
methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→4-bromo-2-methyl-6-nitroaniline→butyraldehyde→6-bromo-4-methyl-2-propyl-1H-benzo[d]imidazole→4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane)→TELM-025→TELM-026→2-bromo-1-methyl-1H-benzo[d]imidazole
1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole→o-cresol→4-hydroxy-3-methylbenzaldehyde→4-hydroxy-3-methyl-5-nitrobenzaldehyde→4-methoxy-3-methyl-5-nitrobenzaldehyde→benzene-1,2-diamine→2-(4-methoxy-3-methyl-5-nitrophenyl)-1-methyl-1H-benzo[d]imidazole→2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)-6-nitroaniline→methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→methyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate
methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→4-bromo-2-methyl-6-nitroaniline→butyraldehyde→6-bromo-4-methyl-2-propyl-1H-benzo[d]imidazole→4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane)→TELM-025→TELM-026→2-bromo-1-methyl-1H-benzo[d]imidazole
1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole→o-cresol→4-hydroxy-3-methylbenzaldehyde→4-hydroxy-3-methyl-5-nitrobenzaldehyde→4-methoxy-3-methyl-5-nitrobenzaldehyde→benzene-1,2-diamine→2-(4-methoxy-3-methyl-5-nitrophenyl)-1-methyl-1H-benzo[d]imidazole→2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)-6-nitroaniline→methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→methyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate
methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→4-bromo-2-methyl-6-nitroaniline→butyraldehyde→6-bromo-4-methyl-2-propyl-1H-benzo[d]imidazole→4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane)→TELM-025→TELM-026→2-bromo-1-methyl-1H-benzo[d]imidazole
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.